Submitted:
26 October 2024
Posted:
29 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Study Aims
1.2. Specific Aims
- Investigate the direct effect of alpha particle radiation on four cutaneous lines of human derived melanoma and their brain metastatic derivatives.
- Look for variations among the variants’ cytotoxic effect.
- Compare the response of melanoma cells to alpha radiation to that of squamous cell carcinoma cells.
- Investigate the correlation between the cytotoxic effect of alpha radiation and the formation of double strand breaks.
- Investigate the correlation between the cytotoxic effect of alpha radiation and the average size of cell nuclei.
- Compare the sensitivity of melanoma cells to alpha radiation with their sensitivity to photon radiation (gamma radiation).
- Investigate DNA double strand breaks inflicted by alpha radiation in combination with modifiers of DNA repair mechanisms, to enhance cell mortality, such as ATR inhibitors (berzosertib) and topoisomerase 1 inhibitor (irinotecan).
- Investigate the cytotoxic effect of alpha radiation on synchronized cell culture after serum starvation to determine the significance of the cell cycle.
2. Materials and Methods
2.1. Cell Lines
2.2. Cell Growth Curves
2.3. In Vitro Irradiation with Alpha Particles Using an 241Americium (Am-241) Irradiator
2.3.1. In Vitro Irradiation Apparatus
2.3.2. Alpha Radiation In-Vitro Procedure
2.4. Colorimetric (HemaColor) Viability Assay
2.5. Exposure of Melanoma Cells to γ-Radiation
2.6. Cell Nuclei Analysis
2.7. Double Strand DNA Breaks Signaling
2.8. Immunofluorescence Assay of γ-H2aX Foci
2.9. Viability Assay: D50 Measurements
2.10. Serum Starvation and Alpha Radiation
3. Results
3.1. Sensitivity of Melanoma Cell Lines and Their Brain Metastatic Variants to Alpha Radiation
3.2. Comparison of Melanoma Cells with Squamous Cell Carcinoma Cells
3.3. Morphology of the Cell Nucleus as a Determinant of the Cytotoxic Effect of Alpha Particle Radiation
3.4. Exposure of Cells to Alpha Particle Caused DNA Double Strand Breaks (DSB) as Measured by γ-H2aX Foci
3.5. Alpha Radiation Is More Cytotoxic to Melanoma Cells in Comparison with Gamma Radiation

3.6. Cell Cycle Synchronization and Proliferation Arrest Did Not Affect Cell Killing by Alpha Radiation
3.7. Cell Cycle Analysis
3.8. Effect of Cell Starvation on the Killing of Cells by Alpha Radiation
3.9. Combination Treatment with DNA Damage Repair Modifiers and Alpha Radiation
3.9.1. Drug Calibration Curves
3.9.2. Combination Treatment with Alpha Radiation
3.10. Cell Death Kinetics Analysis

4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- https://www.who.int/news-room/factsheets/detail/cancer.
- https://www.skincancer.org/skin-cancer-information/melanoma/.
- Izraely, S.; Ben-Menachem, S.; Sagi-Assif, O.; Meshel, T.; Marzese, D.M.; Ohe, S.; Zubrilov, I.; Pasmanik-Chor, M.; Hoon, D.S.B.; Witz, I.P. ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis. Oncotarget 2017, 8, 75778–75796. [Google Scholar] [CrossRef] [PubMed]
- Baskar, R.; Lee, K.A.; Yeo, R.; Yeoh, K.W. Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 2012, 9, 193–199. [Google Scholar] [CrossRef] [PubMed]
- Durante, M.; Debu, J.; Loeffler, J.S. Physics and biomedical challenges of cancer therapy with accelerated heavy ions. Nat. Rev. Phys. 2021, 3, 777–790. [Google Scholar] [CrossRef]
- Williamson, J.F. Brachytherapy technology and physics practice since 1950: a half-century of progres. Phys. Med. Biol. 2006, 51, R303–R325. [Google Scholar] [CrossRef] [PubMed]
- Skowronek, J. Current status of brachytherapy in cancer treatment - short overview. J. Contemp. Brachytherapy 2017, 9, 581–589. [Google Scholar] [CrossRef] [PubMed]
- Pouget, J. P. Mather, S. J. General aspects of the cellular response to low- and high-LET radiation. Eur. J. Nucl. Med. 2001, 28, 541–561. [Google Scholar] [CrossRef]
- Goodhead, D.T. Initial events in the cellular effects of ionizing radiation: Clustered damage in DNA. Int. J. Radiat. Biol. 1994, 65, 7–17. [Google Scholar] [CrossRef]
- Stenerlow, B.; Hoglund, E.; Carlsson, J.; et al. Rejoining of DNA fragments produced by radiations of different linear energy transfer. Int. J. Radia.t Biol. 2000, 6, 549–557. [Google Scholar] [CrossRef]
- Bouffler, S.D.; Haines, J.W.; Edwards, A.A.; et al. Lack of detectable transmissible chromosomal instability after in vivo or in vitro exposure of mouse bone marrow cells to Ra-224 alpha particles. Radiat. Res. 2001, 158, 345–352. [Google Scholar] [CrossRef]
- Belli, M.; Cherubini, R.; Dalla Vecchia, M.; et al. DNA fragmentation in V79 cells irradiated with light ions as measured by PFGE I Experimental results. Int. J. Radiat. Biol. 2006, 78, 475–482. [Google Scholar] [CrossRef]
- Hada, M.; Georgakilas, A.G. Formation of clustered DNA damage after high-LET irradiation: a review. J. Radiat. Res. (Tokyo) 2008, 49, 203–210. [Google Scholar] [CrossRef] [PubMed]
- Milligan, J.R.; Aguilera, J.A.; Paglinawan, R. A et al. Modification of ionizing radiation clustered damage: estimate of the migration distance of holes through DNA via guanyl radicals under physiological conditions. Int. J. Radiat. Biol. 2002, 78, 733–741. [Google Scholar] [CrossRef] [PubMed]
- Asaithamby, A.; Hu, B.; Chen, D.J. Unrepaired clustered DNA lesions induce chromosome breakage in human cells. PNAS 2011, 108, 8293–8298. [Google Scholar] [CrossRef] [PubMed]
- Mulford, D.A.; Scheinberg, D.A. Jurcic, J.G. The promise of targeted alpha-particle therapy. J. Nucl. Med.
- Hall, E.J.; Giaccia, A.J. ; editors. Radiobiology for the Radiologist; Lippincott Williams and Wilkins 2006.
- Raju, M.R; Eisen, Y.; Carpenter, S.; et al. Radiobiology of alpha particles. III. Cell inactivation by alpha particle traversals of the cell nucleus. Radiat. Res. 1991, 128, 204–209. [Google Scholar] [CrossRef] [PubMed]
- Charlton, D.E. Turner, M.S. Technical report: use of chord lengths through the nucleus to simulate the survival of mammalian cells exposed to high LET α-radiation. Int. J. Radiat. Biol. 1996, 69, 213–217. [Google Scholar] [CrossRef]
- Goodhead, D.T. Mechanisms for the biological effectiveness of high-LET radiations. J. Radiat. Res. 1999, 40, Suppl–1. [Google Scholar] [CrossRef]
- Prise, K.M.; Schettino, G.; Folkard, M.; et al. New insights on cell death from radiation exposure. Lancet Oncol. 2005, 6, 520–528. [Google Scholar] [CrossRef]
- Roeske, J.C.; Stinchcomb, T.G. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population. Phys. Med. Biol. 2006, 51, N179–N186. [Google Scholar] [CrossRef]
- Søyland, C.; Hassfjell, S.P. Survival of human lung epithelial cells following in vitro α-particle irradiation with absolute determination of the number of a-particle traversals of individual cells. Int. J. Radiat. Biol. 2000, 76, 1315–1322. [Google Scholar]
- Arazi, L.; Cooks, T.; Schmidt, M.; Keisari, Y.; Kelson, I. Treatment of solid tumours by interstitial release of recoiling short-lived alpha emitters. Phys. Med. Biol. 2007, 52, 5025–5042. [Google Scholar] [CrossRef]
- Cooks, T.; Schmidt, M.; Bittan, H.; Lazarov, E.; Arazi, L.; Kelson, I.; Keisari, Y. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with Radium-224. Int. J. Rad. Oncol. Biol. & Phys. 2009, 74, 966–973. [Google Scholar]
- Keisari, Y.; Popovtzer, A.; Kelson, I. Effective treatment of metastatic cancer by an innovative intratumoral alpha particle-mediated radiotherapy in combination with immunotherapy: A short review. J. Physics: Conference Series; 2020, 1662, 012016. [Google Scholar] [CrossRef]
- Lazarov, E.; Arazi, L.; Efrati, M.; Cooks, T.; Schmidt, M.; Keisari, Y.; Kelson, I. Comparative in vitro microdosimetric study of murine- and human-derived cancer cells exposed to alpha particles. Radiat. Res. 2012, 177, 280–287. [Google Scholar] [CrossRef] [PubMed]
- Popovtzer, A.; Rosenfeld, E.; Mizrachi, A.; et al. Initial safety and tumor control results from a “first-in-human” multicenter prospective trial evaluating a novel alpha-emitting radionuclide for the treatment of locally advanced recurrent squamous cell carcinomas of the skin and head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2020, 106, 571–578. [Google Scholar] [CrossRef]
- D’Andrea, M.A.; VanderWalde, N.A.; Ballo, T.; Patra, P.; Cohen, G.N.; Damato, A.L.; Barker, C.A. Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy for Recurrent or Unresectable Skin Cancers. JAMA Netw. Open 2023, 6, e2312824. [Google Scholar] [CrossRef]
- Siegel, R.L.; Miller, K.D.; Wagle, N.S.; Jemal, A. Cancer statistics; 2023. CA Cancer J. Clin. 2023, 73, 17–48. [Google Scholar] [CrossRef]
- Long, G.V.; Swetter, S.M.; Menzies, A.M.; Gershenwald, J.E.; Scolyer, R.A. Cutaneous melanoma. Lancet 2023, 402(1040), 485–502. [Google Scholar] [CrossRef]
- Mahadevan, A.; Patel, V.L.; Dagoglu, N. Radiation Therapy in the Management of Malignant Melanoma. Oncology (Williston Park) 2015, 29, 743–751. [Google Scholar]
- Fort, M.; Guet, S.; Husheng, S.; Calitchi, E.; Belkacemi, Y.; AROME (Association of Radiotherapy & Oncology of the Mediterranean arEa; www.aromecancer.org), TRONE (Transatlantic Radiation Oncology NEtwork). Erratum to “Role of radiation therapy in melanomas: Systematic review and best practice in 2015” [Crit. Rev. Oncol./Hematol. 99 (2016) 362-375]. Crit. Rev. Oncol. Hematol. 2016, 102, 144. [Google Scholar] [CrossRef]
- Izraely, S.; Sagi-Assif, O.; Klein, A.; Meshel, T.; Tsarfaty, G.; Pasmanik-Chor, M.; Nahmias, C.; Couraud, P.O.; Ateh, E.; Bryantm, J.L.; et al. The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis. Int. J. Cancer 2012, 131, 1071–1082. [Google Scholar] [CrossRef]
- Keisari, Y. A colorimetric microtiter assay for the quantitation of cytokine activity on adherent tissue culture cells. J. Immunol. Meth. 1992, 146, 155–161. [Google Scholar] [CrossRef] [PubMed]
- Nishri, Y.; Vatarescu, M.; Luz, I.; Epstein, L.; Dumancic, M.; Del Mare, S.; Shai, A.; Schmidt, M.; Deutsch, L.; Den, R.B.; Kelson, I.; Keisari, Y.; Arazi, L.; Cooks, T.; Domankevich, V. Diffusing Alpha-emitters Radiation Therapy in Combination with Temozolomide or Bevacizumab in Human Glioblastoma Multiforme Xenografts. Front. Oncol. 2022, 12, 888100. [Google Scholar] [CrossRef] [PubMed]
- Ziegler, J.F.; Ziegler, M.D.; Biersack, J.P. SRIM – the stopping and range of ions in matter. In: Nuclear instruments and methods in physics research section b: Beam interactions with materials and atoms. Elsevier B.V. 2010, 1818–1823.
- Kuo, L.J.; Yang, L.X. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 2008, 22, 305–309. [Google Scholar] [PubMed]
- Huang, R-X. ; Zhou, P-K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Sig. Transduct. Target Ther. 2020, 5, 1–27. [Google Scholar]
- Venkatesh, P.; Panyutin, I.V.; Remeeva, E.; Neumann, R.D.; Panyutin, I.G. Effect of Chromatin Structure on the Extent and Distribution of DNA Double Strand Breaks Produced by Ionizing Radiation; Comparative Study of hESC and Differentiated Cells Lines. Int. J. Mol. Sci. 2016, 17, 58. [Google Scholar] [CrossRef]
- Shin, S.; Hong, S.W.; Lee, S.L.; Kim, T.H.; Park, I.C.; An, S.K.; Lee, W.K.; Lim, J.S.; Kim, K.I.; Yang, Y.; Lee, S.S.; Jin, D.H.; Lee, M.S. Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells. Int. J. Oncol. 2008, 32, 435–439. [Google Scholar] [CrossRef]
- Horev-Drori, G.; Cooks, T.; Bittan, H.; Lazarov, E.; Schmidt, M.; Arazi, L.; Efrati, M.; Kelson, I.; Keisari, Y. Local control of malignant pancreatic tumors by a combined treatment with intratumoral 224Radium-loaded wires releasing alpha-emitting atoms and chemotherapy. Transl. Res. 2012, 159, 32–41. [Google Scholar] [CrossRef]
- Cooks, T.; Tal, M.; Raab, S.; Efrati, M.; Reitkopf, S.; Lazarov, E.; Etzyoni, R.; Schmidt, M.; Arazi, L.; Kelson, I.; Keisari, Y. Intratumoral Ra-224-loaded wires spread alpha emitting atoms inside solid human tumors in athymic mice and can achieve local tumor control. Anticancer Res. 2012, 32, 5315–5321. [Google Scholar]
- Milrot, E.; Jackman, A.; Flescher, E.; Gonen, P.; Kelson, I.; Keisari, Y.; Sherman, L. Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin; X or alpha radiation Invest. New Drugs 2013, 31, 333–344. [Google Scholar] [CrossRef]
- Aninditha, K.P.; Weber, K.J.; Brons, S.; Debus, J.; Hauswald, H. In vitro sensitivity of malignant melanoma cells lines to photon and heavy ion radiation. Clin. Transl. Radiat. Oncol. 2019, 17, 51–56. [Google Scholar] [CrossRef]
- Pugliese, M.; Durante, M.; Grossi, G.F.; Monforti, F.; Orlando, D.; Ottolenghi, A.; Scampoli, P.; Gialanella, G. Inactivation of individual mammalian cells by single alpha-particles. Int. J. Radiat. Biol. 1997, 72, 397–407. [Google Scholar] [CrossRef] [PubMed]
- Mahaney, B.L.; Meek, K.; Lees-Miller, S.P. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem. J. 2009, 417, 639–650. [Google Scholar] [CrossRef] [PubMed]
- Allen, C.; Her, S.; Jaffray, D.A. Radiotherapy for Cancer: Present and Future. Adv. Drug Deliv. Rev. 2017, 109, 1–2. [Google Scholar] [CrossRef] [PubMed]
- Rydberg, B.; Lobrich, M.; Cooper, P.K. Repair of clustered DNA damage caused by high LET radiation in human fibroblasts. Phys. Med. 1998, 1, 24–28. [Google Scholar]
- de Toledo, S.M.; Azzam, E.I. Adaptive and bystander responses in human and rodent cell cultures exposed to low level ionizing radiation: the impact of linear energy transfer. Dose Response 2006, 27, 291–301. [Google Scholar] [CrossRef]
- Moshe, A.; Izraely, S.; Sagi-Assif, O.; Malka, S.; Ben-Menachem, S.; Meshel, T.; Pasmanik-Chor, M.; Hoon, D.S.B.; Witz, I.P. Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation. Cells 2020, 9, 1683. [Google Scholar] [CrossRef]
- Miao, Y.; Hylarides, M.; Fisher, D.R.; Shelton, T.; Moore, H.; Wester, D.W.; Fritzberg, A.R.; Winkelmann, C.T.; Hoffman, T.; Quinn, T.P. Melanoma therapy via peptide-targeted {alpha}-radiation. Clin. Cancer Res. 2005, 11, 5616–5621. [Google Scholar] [CrossRef]
- Newman, H.C.; Prise, K.M.; Folkard, M.; et al. DNA double-strand break distributions in X-ray and a-particle irradiated V79 cells: evidence for non-random breakage. Int. J. Radiat. Biol. 1997, 71, 347–363. [Google Scholar]
- Sambade, M.J.; Peters, E.C.; Thomas, N.E.; Kaufmann, W.K.; Kimple, R.J.; Shields, J.M. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother. Oncol. 2011, 98, 394–399. [Google Scholar] [CrossRef]
- Wéra, A.C.; Barazzuol, L.; Jeynes, J.C.; Merchant, M.J.; Suzuki, M.; Kirkby, K.J. Influence of the nucleus area distribution on the survival fraction after charged particles broad beam irradiation. Phys. Med. Biol. 2014, 59, 4197–4211. [Google Scholar] [CrossRef]
- DeCunha, J.M.; Villegas, F.; Vallières, M.; Torres, J.; Camilleri-Broët, S. ; Enger,S.A. Patient-specific microdosimetry: a proof of concept Phys Med Biol. 2021, 66(18). 66.
- Moroni, M.; Maeda, D.; Whitnall, M.H.; Bonner, W.M.; Redon, C.E. Evaluation of the gamma-H2AX assay for radiation biodosimetry in a swine model. Int. J. Mol. Sci. 2013, 14, 14119–14135. [Google Scholar] [CrossRef] [PubMed]
- Graf, F.; Fahrer, J.; Maus, S.; Morgenstern, A.; Bruchertseifer, F.; Venkatachalam, S.; Fottner, C.; Weber, M.M.; Huelsenbeck, J.; Schreckenberger, M.; Kaina, B.; Miederer, M. DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy. PLoS One 2014, 9. [Google Scholar] [CrossRef] [PubMed]
- Georgakilas, A.G.; O’Neill, P.; Stewart, R.D. Induction and repair of clustered DNA lesions: what do we know so far? Radiat. Res. 2013, 180, 100–109. [Google Scholar] [CrossRef] [PubMed]
- Lorat, Y.; Timm, S.; Jakob, B.; et al. Clustered double-strand breaks in heterochromatin perturb DNA repair after high linear energy transfer irradiation. Radiother. Oncol. 2016, 121, 154–161. [Google Scholar] [CrossRef]
- Shiloh, Y. The ATM-Mediated DNA-Damage Response: Taking Shape. Trends in Biochmical Sci. 2006, 31, 402–410. [Google Scholar] [CrossRef]
- Su, T.T. Cellular Response to DNA Damage: One Signal; Multiple Choices. Annu. Rev. Genet. 2006, 40, 187–208. [Google Scholar] [CrossRef]
- Bartkova, J.; Bakkenist, C.J.; Rajpert-De Meyts, E.; et al. ATM Activation in Normal Human Tissues and Testicular Cancer. Cell cycle 2005, 4, 838–845. [Google Scholar] [CrossRef]
- Kinner, A.; Wu, W.; Staudt, C.; et al. γ-H2AX in recognition and signaling of DNA double-strands breaks in the context of chromatin. Nucleic Acids Res. 2008, 36, 5678–5694. [Google Scholar] [CrossRef]
- Luger, K.; Mäder, A.W.; Richmond, R.K.; Sargent, D.F.; Richmond, S.; Richmond, T.J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature protocols 1997, 389, 251–260. [Google Scholar] [CrossRef]
- Stiff, T.; O’Driscoll, M.; Rief, N.; et al. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004, 64, 2390–2396. [Google Scholar] [CrossRef]
- Rogakou, E.P.; Pilch, D.R.; Orr, A.H; et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273, 5858–5868. [Google Scholar] [CrossRef] [PubMed]
- Pilch, D.R.; Sedelnikova, O.A.; Redon, C.; et al. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem. Cell Biol. 2003, 81, 123–129. [Google Scholar] [CrossRef] [PubMed]
- Sedelnikova, O.A.; Rogakou, E.P.; Panyutin, I.G.; et al. Quantitative detection of 125-IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat. Res. 2002, 158, 486–492. [Google Scholar] [CrossRef] [PubMed]
- Andegeko, Y.; Moyal, L.; Mittelman, L.; et al. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 2001, 276, 38224–38230. [Google Scholar] [CrossRef]
- Burma, S.; Chen, B.P.; Murphy, M.; et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276, 42462–42467. [Google Scholar] [CrossRef]
- Van den Bosch, M.; Bree, R.T.; Lowndes, N.F. The MRN Complex: coordinating and mediating the response to broken chromosomes. EMBO reports 2003, 4, 844–849. [Google Scholar] [CrossRef]
- Wang, H.; Wang, M.; Wang, H.; et al. Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors. J. Cell. Physiol. 2005, 202, 492–502. [Google Scholar] [CrossRef]
- Lemaître, C.; Grabarz, A.; Tsouroula, K.; Andronov, L.; Furst, A.; Pankotai, T.; Heyer, V.; Rogier, M.; Attwood, K.M.; Kessler, P.; Dellaire, G.; Klaholz, B.; Reina-San-Martin, B.; Soutoglou, E. Nuclear position dictates DNA repair pathway choice. Genes Dev. 2014, 28, 2450–2463. [Google Scholar] [CrossRef]
- Cann, K.L.; Dellaire, G. Heterochromatin and the DNA damage response: the need to relax Biochem. Cell Biol. 2011, 89, 45–60. [Google Scholar]
- Goodarzi, A.A.; Jeggo, P.A. The heterochromatic barrier to DNA double strand break repair: how to get the entry visa. Int. J. Mol. Sci. 2012, 13, 11844–11860. [Google Scholar] [CrossRef]
- Svetličič, M.; Bomhard, A.; Sterr, C.; Brückner, F.; Płódowska, M.; Lisowska, H.; Lundholm, L. Alpha Radiation as a Way to Target Heterochromatic and Gamma Radiation-Exposed Breast Cancer. Cells. Cells 2020, 9, 1165. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Larraza, D.M.; Bianchi, N.O. DNA response to bleomycin in mammalian cells with variable degrees of chromatin condensation Environ. Mol Mutagen. 1993, 21, 258–264. [Google Scholar] [CrossRef] [PubMed]
- Foray, N.; Charveta, A.M.; Ducheminb, D.; Favaudonc, V.; Lavaletted, D. The repair rate of radiation-induced DNA damage: A stochastic interpretation based on the Gamma function J. Theor. Biol. 2005, 236, 448–458. [Google Scholar] [CrossRef] [PubMed]
- Falk, M.; Lukášová, E.; Kozubek, S. Chromatin structure influences the sensitivity of DNA to γ-radiation. Biochim. et Biophys. Acta 2008, 1783, 2398–2414. [Google Scholar] [CrossRef]
- Morgan, M.A; Lawrence, T.S. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways. Clin. Cancer Res. 2015, 21, 2898–2904. [Google Scholar] [CrossRef]
- Karnitz, L.M.; Zou, L. Molecular Pathways: Targeting ATR in Cancer Therapy. Clin. Cancer Res. 2015, 21, 4780–4785. [Google Scholar] [CrossRef]
- Baschnagel, A.M.; Elnaggar, J.H.; VanBeek, H.J.; Kromke, A.C.; Skiba, J.H.; Kaushik, S.; Abel, L.; Clark, P.A.; Longhurst, C.A.; Nickel, K.P.; Leal, T.A.; Zhao, S.G.; Kimple, R.J. ATR Inhibitor M6620 (VX-970) Enhances the Effect of Radiation in Non-Small Cell Lung Cancer Brain Metastasis Patient-Derived Xenografts. Mol. Cancer Ther. 2021, 20, 2129–2139. [Google Scholar] [CrossRef]
- Faulhaber, E.M.; Jost, T.; Symank, J.; Scheper, J.; Bürkel, F.; Fietkau, R.; Hecht, M.; Distel, L.V. Kinase Inhibitors of DNA-PK; ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells. Genes (Basel) 2021, 12, 925. [Google Scholar] [CrossRef]
- Tu, X.; Kahila, M.M.; Zhou, Q.; Yu, J.; Kalari, K.R.; Wang, L.; Harmsen, W.S.; Yuan, J.; Boughey, J.C.; Goetz, M.P.; Sarkaria, J.N.; Lou, Z.; Mutter, R.W. ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. Mol. Cancer Ther. 2018, 17, 2462–2472. [Google Scholar] [CrossRef]
- Bannik, K.; Madas, B.; Jarke, S.; et al. DNA repair inhibitors sensitize cells differently to high and low LET radiation. Sci. Rep. 2021, 11, 23257. [Google Scholar] [CrossRef]
- Boothman, D.A.; Wang, M.; Schea, R.A.; Burrows, H.L.; Strickfaden, S.; Owens, J.K. Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int. J. Radiat. Oncol. Biol. Phys. 1992, 24, 939–948. [Google Scholar] [CrossRef]
- Chen, A.Y.; Okunieff, P.; Pommier, Y.; Mitchell, J.B. Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives. Cancer Res. 1997, 57, 1529–1536. [Google Scholar]






Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).